Koch Kevin: insider trades.
Koch Kevin reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($785K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- KOCH KEVIN
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | Director, Officer · President and CEO | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-12 | Edgewise Therapeutics, Inc. | S | 8,276 | $43.66 | 53,401 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | S | 8,782 | $43.64 | 61,677 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | M | 21,875 | $0 | 70,459 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | M | 17,969 | $0 | 48,584 | Form 4 |
| 2026-08-12 | Edgewise Therapeutics, Inc. | S | 913 | $44.33 | 52,488 | Form 4 |
Questions
What stock did Koch Kevin buy or sell?
Koch Kevin reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($785K), across 1 company.
Is Koch Kevin the same person as other filers with this name?
This page covers SEC CIK 1185829 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/koch-kevin-1185829.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.